Eva Marie Jacobsen
- Head of section; Dr. med.
- +47 23 02 65 12
Publications 2024
Non-Skewed X-inactivation Results in NF-κB Essential Modulator (NEMO) Δ-exon 5-autoinflammatory Syndrome (NEMO-NDAS) in a Female with Incontinentia Pigmenti
J Clin Immunol, 45 (1), 1
DOI 10.1007/s10875-024-01799-2, PubMed 39264518
Chemotherapy for a secondary malignancy nearly restores complete chimerism in an SCID-patient after HSCT
Clin Immunol, 259, 109891
DOI 10.1016/j.clim.2024.109891, PubMed 38185266
Publications 2023
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
Sci Immunol, 8 (79), eade7953
DOI 10.1126/sciimmunol.ade7953, PubMed 36662884
Novel mutation and expanding phenotype in IRF2BP2 deficiency
Rheumatology (Oxford), 62 (4), 1699-1705
DOI 10.1093/rheumatology/keac575, PubMed 36193988
Arterial events in cancer patients treated with apixaban for venous thrombosis
Thromb Res, 228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation
J Exp Med, 221 (1)
DOI 10.1084/jem.20230927, PubMed 37962568
Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children
EMBO Rep, 24 (12), e57912
DOI 10.15252/embr.202357912, PubMed 37818799
Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signals
Blood Adv, 7 (20), 6367-6380
DOI 10.1182/bloodadvances.2023010817, PubMed 37428869
Long-term haematological response and maintained immunological function after laparoscopic subtotal splenectomy in patients with hereditary spherocytosis
Eur J Haematol, 111 (5), 777-786
DOI 10.1111/ejh.14077, PubMed 37700575
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Front Pediatr, 11, 1020865
DOI 10.3389/fped.2023.1020865, PubMed 37051428
Publications 2022
Pulmonary Function and Persistent Clinical Symptoms in Children and Their Parents 12 Months After Mild SARS-CoV-2 Infection
Front Pediatr, 10, 894331
DOI 10.3389/fped.2022.894331, PubMed 35844730
Positive and negative selection shape the human naive B cell repertoire
J Clin Invest, 132 (2)
DOI 10.1172/JCI150985, PubMed 34813502
Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays
Blood, 140 (2), 140-151
DOI 10.1182/blood.2021014708, PubMed 35486842
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study
EBioMedicine, 84, 104245
DOI 10.1016/j.ebiom.2022.104245, PubMed 36155957
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
Nat Commun, 13 (1), 7315
DOI 10.1038/s41467-022-35055-1, PubMed 36437276
Role of ABO Blood Group in SARS-CoV-2 Infection in Households
Front Microbiol, 13, 857965
DOI 10.3389/fmicb.2022.857965, PubMed 35602077
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
J Thromb Haemost, 20 (5), 1166-1181
DOI 10.1111/jth.15666, PubMed 35114046
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
J Thromb Haemost, 20 (8), 1937-1939
DOI 10.1111/jth.15774, PubMed 35859282
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0228, PubMed 36655971
Hyper-IgE and Carcinoma in CADINS Disease
Front Immunol, 13, 878989
DOI 10.3389/fimmu.2022.878989, PubMed 35651609
Robust and durable serological response following pediatric SARS-CoV-2 infection
Nat Commun, 13 (1), 128
DOI 10.1038/s41467-021-27595-9, PubMed 35013206
Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS
EMBO Mol Med, 14 (3), e14901
DOI 10.15252/emmm.202114901, PubMed 35170849
Publications 2021
More severe than CVID: Combined immunodeficiency due to a novel NFKB2 mutation
Pediatr Allergy Immunol, 32 (4), 793-797
DOI 10.1111/pai.13441, PubMed 33369776
BCG Disease in SCID: Three Decades of Experience in a Pediatric Transplant Center
J Clin Immunol, 42 (1), 195-198
DOI 10.1007/s10875-021-01143-y, PubMed 34622389
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
Vaccines (Basel), 9 (8)
DOI 10.3390/vaccines9080918, PubMed 34452043
Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies
J Clin Immunol, 42 (2), 286-298
DOI 10.1007/s10875-021-01156-7, PubMed 34716846
Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations
Front Immunol, 12, 739675
DOI 10.3389/fimmu.2021.739675, PubMed 34594342
Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
Case Rep Obstet Gynecol, 2021, 4393821
DOI 10.1155/2021/4393821, PubMed 34513101
One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency
Front Immunol, 12, 680334
DOI 10.3389/fimmu.2021.680334, PubMed 34421895
Publications 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
Thromb Res, 196, 238-244
DOI 10.1016/j.thromres.2020.08.042, PubMed 32919178
Matched Family Donor Lymphocyte Infusions as First Cellular Therapy for Patients with Severe Primary T Cell Deficiencies
Transplant Cell Ther, 27 (1), 93.e1-93.e8
DOI 10.1016/j.bbmt.2020.09.037, PubMed 33022377
Successful hematopoietic stem cell transplantation in a 4-1BB deficient patient with EBV-induced lymphoproliferation
Clin Immunol, 222, 108639
DOI 10.1016/j.clim.2020.108639, PubMed 33259966
Publications 2019
Elevated Complement C3 and C4 Levels are Associated with Postnatal Pregnancy-Related Venous Thrombosis
Thromb Haemost, 119 (9), 1481-1488
DOI 10.1055/s-0039-1692426, PubMed 31254974
[Analysis of lupus anticoagulant during ongoing anticoagulation therapy]
Tidsskr Nor Laegeforen, 139 (15)
DOI 10.4045/tidsskr.19.0096, PubMed 31642626
Analysis of lupus anticoagulant during ongoing anti coagulation treatment
Tidsskr. Nor. Laegeforen., 139 (15), 1491
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML
Blood Adv, 3 (22), 3674-3687
DOI 10.1182/bloodadvances.2018030478, PubMed 31765481
The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis
Thromb Res, 177, 154-156
DOI 10.1016/j.thromres.2019.03.010, PubMed 30903875
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency
J Allergy Clin Immunol, 143 (6), 2296-2299
DOI 10.1016/j.jaci.2019.02.003, PubMed 30771411
NK Cells from RAG- or DCLRE1C-Deficient Patients Inhibit HCMV
Microorganisms, 7 (11)
DOI 10.3390/microorganisms7110546, PubMed 31717670
Publications 2018
Late thymic deficiency after HLA-haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency
J Allergy Clin Immunol, 143 (4), 1623-1626.e13
DOI 10.1016/j.jaci.2018.11.027, PubMed 30529243
Anxiety, depression and relationship satisfaction in the pregnancy following stillbirth and after the birth of a live-born baby: a prospective study
BMC Pregnancy Childbirth, 18 (1), 41
DOI 10.1186/s12884-018-1666-8, PubMed 29361916
RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia
PLoS One, 13 (4), e0196181
DOI 10.1371/journal.pone.0196181, PubMed 29672642
Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis
Mol Cell Pediatr, 5 (1), 1
DOI 10.1186/s40348-018-0079-0, PubMed 29352427
The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis
Platelets, 31 (1), 43-47
DOI 10.1080/09537104.2018.1557618, PubMed 30569801
Publications 2017
Healthcare utilisation, induced labour and caesarean section in the pregnancy after stillbirth: a prospective study
BJOG, 125 (2), 202-210
DOI 10.1111/1471-0528.14750, PubMed 28516500
Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome
Blood, 129 (21), 2928-2938
DOI 10.1182/blood-2016-11-745638, PubMed 28331055
Publications 2016
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Scand J Immunol, 84 (2), 95-9
DOI 10.1111/sji.12445, PubMed 27135178
Publications 2015
Compression Stockings for Preventing the Postthrombotic Syndrome in Patients with Deep Vein Thrombosis
Am J Med, 129 (4), 447.e1-447.e20
DOI 10.1016/j.amjmed.2015.11.031, PubMed 26747198
Publications 2014
[Anticoagulation for venous thrombosis and internal diseases]
Tidsskr Nor Laegeforen, 134 (9), 924
DOI 10.4045/tidsskr.13.1597, PubMed 24828715
Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
Chest, 146 (3), 727-734
DOI 10.1378/chest.13-2828, PubMed 25180723
Publications 2013
Women's experiences in relation to stillbirth and risk factors for long-term post-traumatic stress symptoms: a retrospective study
BMJ Open, 3 (10), e003323
DOI 10.1136/bmjopen-2013-003323, PubMed 24154514
Classification of stillbirths and risk factors by cause of death--a case-control study
Acta Obstet Gynecol Scand, 92 (3), 325-33
DOI 10.1111/aogs.12044, PubMed 23157574
Lesson from hypomorphic recombination-activating gene (RAG) mutations: Why asymptomatic siblings should also be tested
J Allergy Clin Immunol, 133 (4), 1211-5
DOI 10.1016/j.jaci.2013.10.021, PubMed 24331380
Publications 2012
Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis
Br J Haematol, 157 (6), 753-61
DOI 10.1111/j.1365-2141.2012.09121.x, PubMed 22533697
Long-term impact of intrauterine fetal death on quality of life and depression: a case-control study
BMC Pregnancy Childbirth, 12, 43
DOI 10.1186/1471-2393-12-43, PubMed 22676992
A new, clinically oriented, unifying and simple placental classification system
Placenta, 33 (12), 1026-35
DOI 10.1016/j.placenta.2012.10.002, PubMed 23110739
Publications 2011
Incidence and risk factors of fetal death in Norway: a case-control study
Acta Obstet Gynecol Scand, 90 (4), 390-7
DOI 10.1111/j.1600-0412.2011.01079.x, PubMed 21306337
The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study
Thromb Res, 130 (1), 32-7
DOI 10.1016/j.thromres.2011.11.029, PubMed 22178574
The association of inherited thrombophilia and intrauterine fetal death: a case-control study
Blood Coagul Fibrinolysis, 22 (8), 651-6
DOI 10.1097/MBC.0b013e32834a614c, PubMed 22198364
Publications 2010
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Blood, 116 (17), 3180-4
DOI 10.1182/blood-2010-06-288647, PubMed 20634373
The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis--a population-based case-control study
Thromb Res, 125 (5), e222-7
DOI 10.1016/j.thromres.2009.12.006, PubMed 20051285
Nonfatal self-poisoning with LMW heparin and the use of antidote
Thromb Res, 126 (5), e403-5
DOI 10.1016/j.thromres.2010.08.026, PubMed 20870279
Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms
J Thromb Haemost, 8 (11), 2443-9
DOI 10.1111/j.1538-7836.2010.04038.x, PubMed 20735725
Publications 2008
Incidence of thromboembolic events in patients with primary Sjögren's syndrome
Scand J Rheumatol, 37 (2), 127-9
DOI 10.1080/03009740701716843, PubMed 18415770
Publications 2007
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
Blood, 110 (4), 1178-83
DOI 10.1182/blood-2007-01-066043, PubMed 17440049
Publications 2006
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene
Thromb J, 4, 3
DOI 10.1186/1477-9560-4-3, PubMed 16436199
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants
Br J Haematol, 136 (1), 131-7
DOI 10.1111/j.1365-2141.2006.06385.x, PubMed 17092306
Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
Cell Death Differ, 14 (3), 480-8
DOI 10.1038/sj.cdd.4402019, PubMed 16902496
Publications 2002
Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin
Thromb Res, 105 (2), 177-82
DOI 10.1016/s0049-3848(01)00420-0, PubMed 11958810
Laboratory diagnosis of the antiphospholipid syndrome
Thromb Res, 108 (5-6), 263-71
DOI 10.1016/s0049-3848(02)00400-0, PubMed 12676184
Publications 2001
Laboratory evaluation of lupus anticoagulants and their interference with coagulation inhibitors
Haematological Research Laboratory, Ullevål University Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 012115037, ISBN 82-91675-16-3
The evaluation of clotting times in the laboratory detection of lupus anticoagulants
Thromb Res, 104 (4), 275-82
DOI 10.1016/s0049-3848(01)00365-6, PubMed 11728529
Publications 2000
The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5
Thromb Haemost, 83 (5), 704-8
PubMed 10823266
Publications 1999
Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?
Thromb Res, 94 (4), 213-20
DOI 10.1016/s0049-3848(98)00195-9, PubMed 10336236
Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome
Hum Mol Genet, 8 (9), 1769-77
DOI 10.1093/hmg/8.9.1769, PubMed 10441342
Publications 1997
A simple procedure that increases the specificity of the activated protein C resistance test in samples containing antiphospholipid antibodies
Thromb Res, 86 (5), 385-91
DOI 10.1016/s0049-3848(97)00083-2, PubMed 9211629
Publications 1996
Lupus anticoagulant and a functional assay for tissue factor pathway inhibitor
Thromb Res, 83 (4), 339-40
DOI 10.1016/0049-3848(96)00142-9, PubMed 8870178
False negative screening tests for lupus anticoagulants--an unrecognized problem?
Thromb Res, 82 (5), 445-51
DOI 10.1016/0049-3848(96)00094-1, PubMed 8771705
Publications 1995
[Does social support have an impact on the prognosis in cancer?]
Tidsskr Nor Laegeforen, 115 (24), 3022-5
PubMed 7570530